AstraZeneca?21 May 2020 11:45
https://twitter.com/afzalvalli/status/1263397880154341377?s=21. -
And also found this
‘Candidate: Monoclonal antibodies to prevent COVID-19 disease.
Category: ANTIBODY
Type: Coronavirus-neutralizing antibodies developed through the company’s program to use the Defense Advances Research Project Agency’s Pandemic Prevention Platform (P3).
Status: AstraZeneca said April 8 it is exploring three potential sources for antibodies against SARS CoV-2: Patients who have recovered from COVID-19, immunized humanized mice, and lab techniques such as phage display: “AstraZeneca is aiming for clinical evaluation in the next 3 to 5 months.” ‘
Interesting combined with this from their website..
‘Researching treatments for COVID-19
There are currently no specific treatments for COVID-19. Researchers across the world, including AstraZeneca, are investigating preventative approaches and treatment options for COVID-19, including monoclonal antibodies, vaccines and antivirals, as well as investigating the repurposing of existing drugs to treat the infection.
A vaccine is a prophylaxis, or preventative, approach against disease. Vaccines require an immunisation and a healthy immune system; they have the potential to provide long-term protection against the virus, though it is estimated that it could take at least a year before a vaccine against COVID-19 is approved.
Monoclonal antibodies synthesised in the laboratory mimic natural antibodies. It is hoped that an antibody-based treatment could neutralise the SARS-CoV-2 virus and thus, in theory, be given as a preventative option for those exposed to the virus, as well as treat and prevent disease progression in patients already infected by the virus. An antibody-based treatment has the potential to provide immediate effect in the patient.‘
NOTE mention of humanized mice! So question is could this be us?
IMHO DYOR GLA